tiprankstipranks
Company Announcements

Optiscan Imaging Sees Revenue Growth Amid Increased R&D Investment

Story Highlights
  • Optiscan Imaging Limited reported a 32% revenue increase for the half-year ended December 2024.
  • The company accelerated R&D efforts, enhancing technology applications in various medical fields.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Optiscan Imaging Sees Revenue Growth Amid Increased R&D Investment

The latest update is out from Optiscan Imaging Limited ( (AU:OIL) ).

Optiscan Imaging Limited reported a 32% increase in revenue for the half-year ended December 2024, driven by higher sales from Carl Zeiss Meditec and increased R&D incentive income. Despite a decrease in net assets and a continued net loss, the company has accelerated its R&D efforts, which are expected to enhance its technology applications across various medical fields.

More about Optiscan Imaging Limited

Optiscan Imaging Limited operates in the medical imaging industry, focusing on developing and providing advanced imaging technologies. The company specializes in products and services related to precision surgery, pathology, telepathology, gastrointestinal, and veterinary applications.

Technical Sentiment Consensus Rating: Strong Sell

Current Market Cap: €80.22M

For a thorough assessment of OIL stock, go to TipRanks’ Stock Analysis page.

Questions or Comments about the article? Write to editor@tipranks.com

Questions or Comments about the article? Write to editor@tipranks.com
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App